Intensive blood pressure lowering: a practical review.
Ageing
Ambulatory blood pressure measurement
Chronic kidney disease
Diabetes mellitus type 2
Heart failure
Intensive blood pressure lowering
Ischemic heart disease
Obesity, cardiovascular risk
Journal
Clinical hypertension
ISSN: 2056-5909
Titre abrégé: Clin Hypertens
Pays: England
ID NLM: 101669508
Informations de publication
Date de publication:
01 Nov 2020
01 Nov 2020
Historique:
received:
03
07
2020
accepted:
10
09
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
epublish
Résumé
According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, estimates of the benefits versus the harm should be based on reliable office BP measurements and home BP measurements.There is still debate about which BP goals are optimal in reducing morbidity and mortality in uncomplicated hypertensives and in those with associated comorbidities. In recent years, trials and meta-analyses have assessed intensive BP lowering, with some success. However, a careful examination of the results shows that current data are not easily applicable to the general hypertensive population.This article reviews the evidence on and controversies about intensive BP lowering in general and in specific clinical situations, and the importance of obtaining reliable BP readings in patients with hypertension and comorbidities.
Identifiants
pubmed: 33292735
doi: 10.1186/s40885-020-00153-z
pii: 10.1186/s40885-020-00153-z
pmc: PMC7603713
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
21Références
J Am Heart Assoc. 2019 Aug 20;8(16):e013098
pubmed: 31423869
PLoS One. 2019 Apr 12;14(4):e0215362
pubmed: 30978254
Hypertension. 2016 Feb;67(2):263-5
pubmed: 26553234
Eur Heart J Cardiovasc Pharmacother. 2020 Nov 1;6(6):356-363
pubmed: 31529024
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
JAMA. 2016 Jun 28;315(24):2673-82
pubmed: 27195814
Korean Circ J. 2020 Jun;50(6):469-475
pubmed: 32281321
Ann Intern Med. 2006 Jun 20;144(12):884-93
pubmed: 16785477
Korean Circ J. 2019 Nov;49(11):1035-1048
pubmed: 31190479
J Hum Hypertens. 2019 Sep;33(9):648-657
pubmed: 31363149
Hypertension. 2020 Feb;75(2):331-338
pubmed: 31865790
Clin Hypertens. 2020 Feb 1;26:3
pubmed: 32021699
Am J Kidney Dis. 2019 Jan;73(1):21-30
pubmed: 30291012
J Clin Hypertens (Greenwich). 2019 Dec;21(12):1813-1820
pubmed: 31670874
Hypertension. 2020 May;75(5):1205-1212
pubmed: 32223381
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
J Am Coll Cardiol. 2017 Feb 7;69(5):486-493
pubmed: 28153104
Hypertension. 2019 Jun;73(6):1291-1299
pubmed: 31030606
Blood Press. 2018 Dec;27(6):314-340
pubmed: 30380928
Circulation. 2018 Oct 23;138(17):e426-e483
pubmed: 30354655
Hypertens Res. 2019 Nov;42(11):1726-1737
pubmed: 31222188
High Blood Press Cardiovasc Prev. 2019 Dec;26(6):483-491
pubmed: 31705461
PLoS One. 2013 Jul 30;8(7):e65174
pubmed: 23935815
J Hum Hypertens. 2018 Sep;32(8-9):633-638
pubmed: 29991704
Clin Hypertens. 2019 Aug 1;25:20
pubmed: 31388453
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
J Hypertens. 2003 Apr;21(4):707-16
pubmed: 12658016
Circ Heart Fail. 2017 Apr;10(4):
pubmed: 28364091
Lancet. 2013 Aug 10;382(9891):507-15
pubmed: 23726159
Hypertension. 2017 Jan;69(1):171-179
pubmed: 27802419
J Am Coll Cardiol. 2016 Apr 5;67(13):1519-1527
pubmed: 27150682
Blood Press Monit. 2007 Jun;12(3):157-66
pubmed: 17496465
Diabetes Res Clin Pract. 2019 Mar;149:69-77
pubmed: 30735770
Lancet. 2014 May 31;383(9932):1899-911
pubmed: 24881994
Korean Circ J. 2020 Jun;50(6):476-484
pubmed: 32281319
J Am Soc Nephrol. 2017 Sep;28(9):2812-2823
pubmed: 28642330
Lancet. 2016 Jan 30;387(10017):435-43
pubmed: 26559744
Am J Med. 2019 Jul;132(7):840-846
pubmed: 30721655
N Engl J Med. 2015 Nov 26;373(22):2103-16
pubmed: 26551272